Accurate identification and classification of leukemic blast cells is
a very important prerequisite of the precise diagnosis of acute leukem
ia and has a great impact on therapy and prognosis. The purpose of thi
s review is to consider, in the broad sense of the word, the present p
ossibilities and limitations of enzyme cytochemistry and to emphasize
how cytochemistry may contribute, on integration with the other method
s of study, to the final classification and differential diagnosis of
acute leukemia, a highly variable hematological disorder. In this revi
ew, the role of conventional enzyme cytochemistry, either dominant or
subsidiary, in the discrimination of acute leukemia subtypes is discus
sed. The survey confirms the absolute necessity of immunologic marker
analysis in the accurate diagnosis of acute lymphoblastic leukemia, un
differentiated or minimally differentiated leukemia and mixed-lineage
leukemia because in these cases, the cytochemical evaluation provides
insufficiently relevant information regarding blast cell origin, speci
ficity of leukemia subtypes and the discrete stages of leukemic cell m
aturation. On the other hand, cytochemical investigation is appreciate
d to be dominant over immunophenotyping in characterizing acute myeloi
d leukemia, because of the lack of specificity of the majority of immu
nological markers against myeloid antigens and, because of the availab
ility of standardized and sufficiently specific cytochemical reactions
. The cytogenetic, molecular biological and electron microscopic studi
es mentioned in this review supplement the important information for c
orrect differential diagnosis of acute leukemia. The prognostic impact
of enzyme cytochemistry in correlation to other methods is evaluated.